EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Galactokinase 1 Inhibition-Induced Cell Cycle Arrest and Apoptosis in Bladder Cancer Cells Is Associated with AKT Signaling Downregulation

Surya P Singh iD, Ronghao Liu, Feng Yan, Qinggong Tang iD, Chinthalapally V Rao iD, Venkateshwar Madka iD

International Journal of Molecular Sciences · 23.03.2026 · 27 (6) · 2911

DOI: 10.3390/ijms27062911 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.03.2026. Verfasst von Surya P Singh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cancer Prevention and Drug Development, Stephenson Cancer Center, Hem-Onc Section, Department of Medicine, University of Oklahoma Health C…. Hauptthemen laut MEDLINE: Apoptosis, Proto-Oncogene Proteins c-akt, Urinary Bladder Neoplasms, Signal Transduction. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institutional Research Grant, American Cancer Society, Kerley-Cade Endowed Chair.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bladder cancer (BCa) is the second most common cancer of the genitourinary tract globally. It has limited treatment options, high recurrence rate, and acquires resistance to platinum-based therapy. Therefore, identifying novel therapeutic targets is urgently needed. Analysis of the TCGA data revealed that the enzyme galactokinase-1 (GALK1) is overexpressed (p < 0.0001) in bladder tumors compared to normal tissue. Our data also confirmed GALK1 protein upregulation in multiple human BCa cell lines and rodent bladder tumors. However, the precise role of GALK1 in BCa progression and effects of its specific inhibitor remain unexamined. In this study, we demonstrate that GALK1 gene silencing using shRNA resulted in a significant reduction in BCa cell proliferation, migration, and invasion. Pharmacological inhibition of GALK1 using small molecule Cpd36 resulted in anticancer efficacy against BCa. Cpd36 inhibited proliferation, migration, and invasion of BCa cells. Further, Cpd36 induced G1 phase cell cycle arrest, apoptosis, mitochondrial membrane depolarization, and ROS production in the BCa cells. Mechanistically, Cpd36-induced reduction in cell proliferation was associated with a decrease in expression of GALK1, PCNA proteins. Inhibition of metastatic potential was accompanied by decreased migration, invasion, and MMP-9 expression. Cell cycle arrest was associated with decrease in Cyclin D1 and increased expression of p21 and p27. Induction of apoptosis was linked with increased expression of cleaved caspase-3 and cleaved PARP, while downregulating p-AKT. Additionally, Cpd36 in combination with cisplatin or gemcitabine showed a strong synergistic effect on BCa cells. Taken together, our findings suggest that GALK1 plays a significant role in BCa cell survival and validates its inhibitors as promising therapeutic options for managing this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ApoptosisProto-Oncogene Proteins c-aktUrinary Bladder NeoplasmsSignal TransductionCell Cycle CheckpointsHumansCell Line, TumorCell ProliferationCell MovementDown-RegulationAnimalsGene Expression Regulation, NeoplasticMembrane Potential, MitochondrialReactive Oxygen Species

Stichwörter der Autor:innen

apoptosisbladder cancercell cyclecpd36galactokinase-1

Substanzen

Proto-Oncogene Proteins c-aktReactive Oxygen Species

Autor:innen und Institutionen

  • Center for Cancer Prevention and Drug Development, Stephenson Cancer Center, Hem-Onc Section, Department of Medicine, University of Oklahoma Health Campus, Oklahoma City, OK 73104, USA.
  • Stephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK 73019, USA.
  • VA Medical Center, Oklahoma City, OK 73104, USA.

ORCID-Profile: Surya P Singh, Qinggong Tang, Chinthalapally V Rao, Venkateshwar Madka

Förderung

  • Institutional Research Grant
  • American Cancer Society
  • Kerley-Cade Endowed Chair
  • National Cancer Institute Cancer Center Support
  • National Science Foundation
  • National Institute of Health
  • Oklahoma Shared Clinical and Translational Resources
  • Oklahoma Center for the Advancement of Science and Technology

Zitieren

APA

Singh, S. P., Liu, R., Yan, F., Tang, Q., Rao, C. V., & Madka, V. (2026). Galactokinase 1 Inhibition-Induced Cell Cycle Arrest and Apoptosis in Bladder Cancer Cells Is Associated with AKT Signaling Downregulation. International Journal of Molecular Sciences, 27(6), 2911. https://doi.org/10.3390/ijms27062911

Vancouver

Singh SP, Liu R, Yan F, Tang Q, Rao CV, Madka V. Galactokinase 1 Inhibition-Induced Cell Cycle Arrest and Apoptosis in Bladder Cancer Cells Is Associated with AKT Signaling Downregulation. International Journal of Molecular Sciences. 2026;27(6):2911. doi:10.3390/ijms27062911

BibTeX
@article{Singh2026,
  author = {Singh, Surya P and Liu, Ronghao and Yan, Feng and Tang, Qinggong and Rao, Chinthalapally V and Madka, Venkateshwar},
  title = {Galactokinase 1 Inhibition-Induced Cell Cycle Arrest and Apoptosis in Bladder Cancer Cells Is Associated with AKT Signaling Downregulation},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {6},
  pages = {2911},
  doi = {10.3390/ijms27062911}
}
Kostenlos starten →